BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9374796)

  • 1. The I1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla.
    Ernsberger P; Haxhiu MA
    Am J Physiol; 1997 Nov; 273(5):R1572-9. PubMed ID: 9374796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.
    Ernsberger P; Haxhiu MA; Graff LM; Collins LA; Dreshaj I; Grove DL; Graves ME; Schäfer SG; Christen MO
    Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():27-41. PubMed ID: 8068578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct evidence for imidazoline (I1) receptor modulation of ethanol action on norepinephrine-containing neurons in the rostral ventrolateral medulla in conscious spontaneously hypertensive rats.
    Li G; Abdel-Rahman AA
    Alcohol Clin Exp Res; 2007 Apr; 31(4):684-93. PubMed ID: 17374048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal norepinephrine responses of the rostral ventrolateral medulla and nucleus tractus solitarius neurons distinguish the I1- from the alpha2-receptor-mediated hypotension in conscious SHRs.
    Li G; Wang X; Abdel-Rahman AA
    J Cardiovasc Pharmacol; 2005 Jul; 46(1):52-62. PubMed ID: 15965355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
    Haxhiu MA; Dreshaj I; Schäfer SG; Ernsberger P
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S1-8. PubMed ID: 7533221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1999 Jun; 881():279-86. PubMed ID: 10415926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites?
    Guyenet PG
    Am J Physiol; 1997 Nov; 273(5):R1580-4. PubMed ID: 9374797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide discriminates the sites and mechanisms of action of centrally acting anti-hypertensive drugs in rabbits.
    Sy GY; Bruban V; Bousquet P; Feldman J
    Neuropharmacology; 2002 Dec; 43(8):1330-8. PubMed ID: 12527483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
    Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Historic aspects in the identification of the I1 receptor and the pharmacology of imidazolines.
    Dominiak P
    Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():21-6. PubMed ID: 8068577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.
    Ernsberger P; Friedman JE; Koletsky RJ
    J Hypertens Suppl; 1997 Jan; 15(1):S9-23. PubMed ID: 9050981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of α2-adrenoceptor/I1-imidazoline receptor in the rostral ventrolateral medulla to cardiovascular regulation is enhanced in conscious spontaneously hypertensive rat.
    Yamazato M; Nakamoto M; Sakima A; Yamazato Y; Takishita S; Ohya Y
    Clin Exp Hypertens; 2019; 41(3):255-262. PubMed ID: 29764227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmane produces hypotension following microinjection into the RVLM: possible role of I(1)-imidazoline receptors.
    Musgrave IF; Badoer E
    Br J Pharmacol; 2000 Mar; 129(6):1057-9. PubMed ID: 10725251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I1-imidazoline receptors: an update.
    Bousquet P; Dontenwill M; Greney H; Feldman J
    J Hypertens Suppl; 1998 Aug; 16(3):S1-5. PubMed ID: 9747903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The imidazoline receptor in control of blood pressure by clonidine and allied drugs.
    Reis DJ; Piletz JE
    Am J Physiol; 1997 Nov; 273(5):R1569-71. PubMed ID: 9374795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological analysis of the role of central alpha-2 adrenergic and imidazoline receptors in mechanism of the hypotensive effect of clonidine in rats].
    Kuz'min AI; Lodygin DN; Kalenikova EI; Bychkova EIu; Khokhlova ON; Murashev AN; Medvedev OS
    Eksp Klin Farmakol; 2000; 63(4):24-8. PubMed ID: 11022301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of I1-imidazoline receptors using microphysiometry and molecular modelling.
    Musgrave IF; Hughes RA
    J Auton Nerv Syst; 1998 Oct; 72(2-3):137-46. PubMed ID: 9851562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.